Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Myasthenia Gravis × rozanolixizumab × Clear all

Phase

Phase 3 6 Phase 4 1 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

Pyridostigmine Bromide 2 Prednisone 2 telitacicept 1 rozanolixizumab 1 ravulizumab 1 efgartigimod alfa 1 Prednisolone 1 Immunoglobulins, Intravenous 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07246564 2026-03-13

Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravis

UCB Pharma

Phase 4 Recruiting

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡